We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+5.41%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$141M
AUM Growth
+$6.43M
Cap. Flow
+$9.56M
Cap. Flow %
6.78%
Top 10 Hldgs %
55.72%
Holding
161
New
36
Increased
33
Reduced
7
Closed
45

Top Buys

Rank Stock Value
1
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
+$8.56M
2
INFO
IHS Markit Ltd. Common Shares
INFO
+$3.47M
3
NUAN
Nuance Communications, Inc.
NUAN
+$3.42M
4
CPARU
Catalyst Partners Acquisition Corp. Unit
CPARU
+$2.01M
5
ATHM icon
Autohome
ATHM
+$1.32M

Top Sells

Rank Stock Value
1
IPHI
INPHI CORPORATION
IPHI
+$3.84M
2
RP
RealPage, Inc.
RP
+$3.37M
3
INDA icon
iShares MSCI India ETF
INDA
+$2.29M
4
GNW icon
Genworth Financial
GNW
+$1.92M
5
BABA icon
Alibaba
BABA
+$1.79M

Sector Composition

Rank Sector Weight
1 Technology 32.85%
2 Healthcare 32.22%
3 Financials 6.7%
4 Communication Services 6.68%
5 Consumer Discretionary 4.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHKP icon
126
Check Point Software Technologies
CHKP
$13.4B
– –
-2,970
Closed -$332K
GNW icon
127
Genworth Financial
GNW
$3.7B
– –
-578,000
Closed -$1.92M
INDA icon
128
iShares MSCI India ETF
INDA
$6.6B
– –
-54,260
Closed -$2.29M
ITOS
129
DELISTED
iTeos Therapeutics
ITOS
– –
-19,804
Closed -$677K
KRON
130
DELISTED
Kronos Bio
KRON
– –
-26,944
Closed -$789K
NGNE icon
131
Neurogene
NGNE
$729M
– –
-3,562
Closed -$877K
NVO
132
Novo Nordisk
NVO
$209B
– –
-10,226
Closed -$345K
ORIC icon
133
Oric Pharmaceuticals
ORIC
$1.41B
– –
-22,333
Closed -$547K
OVID icon
134
Ovid Therapeutics
OVID
$489M
– –
-40,920
Closed -$164K
RNAM
135
DELISTED
Avidity Biosciences
RNAM
– –
-31,797
Closed -$693K
RYTM icon
136
Rhythm Pharmaceuticals
RYTM
$7.95B
– –
-24,809
Closed -$528K
SAGE
137
DELISTED
Sage Therapeutics
SAGE
– –
-10,111
Closed -$757K
SCCO icon
138
Southern Copper
SCCO
$167B
– –
-4,148
Closed -$258K
SLDB icon
139
Solid Biosciences
SLDB
$918M
– –
-6,104
Closed -$506K
STOK icon
140
Stoke Therapeutics
STOK
$2.08B
– –
-13,692
Closed -$532K
STRO icon
141
Sutro Biopharma
STRO
$423M
– –
-3,898
Closed -$887K
TARS icon
142
Tarsus Pharmaceuticals
TARS
$2.97B
– –
-21,084
Closed -$680K
TSM icon
143
TSMC
TSM
$2.17T
– –
-10,016
Closed -$1.19M
UBS icon
144
UBS Group
UBS
$177B
– –
-19,998
Closed -$292K
VHC icon
145
VirnetX Holding Corp
VHC
$60M
– –
-590
Closed -$65K
VKTX icon
146
Viking Therapeutics
VKTX
$4.02B
– –
-10,100
Closed -$64K
VRNA
147
DELISTED
Verona Pharma
VRNA
– –
-36,638
Closed -$306K
VXRT
148
DELISTED
Vaxart
VXRT
– –
-11,600
Closed -$70K
BCEL
149
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
– –
-34,301
Closed -$526K
APTX
150
DELISTED
Aptinyx Inc. Common Stock
APTX
– –
-28,550
Closed -$85K
3 4 5
6
7

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
VIA
Virtus Investment Advisers Hartford, Connecticut $363M AUM 34.89% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $361M AUM 134.26% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

HighVista Strategies's Q2 2021 Portfolio in Review

As of Q2 2021, HighVista Strategies held 161 positions worth $141M, up 4.8% from $135M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

HighVista Strategies deployed $9.56M of net new capital in Q2 2021, opening 36 new positions and adding to 33 existing holdings. Its largest new stake was IHS Markit Ltd. Common Shares: 32,743 shares worth $3.69M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Alibaba, an estimated $1.79M trimmed.

  • HighVista Strategies's largest Q2 2021 buy was IHS Markit Ltd. Common Shares: 32,743 shares worth $3.69M.
  • HighVista Strategies added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, an estimated $8.56M increase.
  • HighVista Strategies's biggest Q2 2021 reduction was Alibaba, cutting an estimated $1.79M.
  • HighVista Strategies fully exited INPHI CORPORATION in Q2 2021, selling an estimated $3.84M.
  • HighVista Strategies's ten largest holdings make up 56% of its $141M portfolio in Q2 2021.
  • HighVista Strategies opened 36 new positions and closed 45 in Q2 2021.
  • HighVista Strategies's portfolio value rose 4.8% quarter-over-quarter to $141M.

Based on HighVista Strategies's 13F filing for Q2 2021, filed 16 Aug 2021.